Clinical Trials Directory

Trials / Terminated

TerminatedNCT01649505

Fibrin Sealant in Preventing Fluid Build Up During Surgery in Patients Undergoing Breast Reconstruction

Intraoperative Use of Fibrin Glue Sealant Combined With Sharp Dissection Technique as a Preventative Measure for Seromas

Status
Terminated
Phase
N/A
Study type
Interventional
Enrollment
2 (actual)
Sponsor
OHSU Knight Cancer Institute · Academic / Other
Sex
Female
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to investigate the efficacy of an alternative surgical technique and the use of fibrin sealant in preventing post-operative seroma formation. A seroma is a build-up of clear bodily fluids in a place on the body where tissue has been removed by surgery. Seromas can happen after breast surgeries. Seromas can appear about 7 to 10 days after surgery, after the drainage tubes have been removed. The breast area involved in the surgery may have a spot that's swollen and feels like there is liquid under the skin

Detailed description

PRIMARY OBJECTIVES: I. To evaluate differing surgical techniques (sharp dissection v. electrosurgical, use of fibrin glue) in latissimus dorsi donor flap harvest and their effect, if any on the prevention of post-operative seromas. OUTLINE: Patients are randomized to 1 of 2 treatment arms. ARM I: Patients undergo sharp dissection technique with fibrin sealant closure. ARM II: Patients undergo standard electrocoagulation dissection technique. After completion of study treatment, patients are followed up for 90-180 days.

Conditions

Interventions

TypeNameDescription
DRUGfibrin sealant (Beriplast P, TISSEEL VH)Applied topically
PROCEDUREbreast reconstructionUndergo sharp dissection technique
PROCEDUREbreast reconstructionUndergo electrocoagulation dissection technique

Timeline

Start date
2011-01-01
Primary completion
2012-01-01
Completion
2012-01-01
First posted
2012-07-25
Last updated
2022-11-02
Results posted
2013-03-15

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01649505. Inclusion in this directory is not an endorsement.